SAN FRANCISCO — In the next few years, publicly traded life sciences companies headquartered in California could collectively need to add hundreds of women to their boards in order to comply with a new state gender-parity law.
That’s going to mean finding women to fill 126 board seats in the sector by the end of 2019. And by the end of 2021, 456 women may need to be recruited to join these boards. All told, across every category of the life sciences sector, at least 85 percent of public California companies will need to add at least one woman to their board by the end of 2021.
About the Author Reprints
